Hakutulokset - Sunfa Cheng

  • Näytetään 1 - 18 yhteensä 18 tuloksesta
Tarkenna hakua
  1. 1
    Gelatinase A (MMP-2) Is Necessary and Sufficient for Renal Tubular Cell Epithelial-Mesenchymal Transformation

    Gelatinase A (MMP-2) Is Necessary and Sufficient for Renal Tubular Cell Epithelial-Mesenchymal Transformation Tekijä Sunfa Cheng, David H. Lovett

    Julkaistu 2003
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs

    HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs Tekijä Tamal Raha, Sunfa Cheng, Michael R. Green

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury

    Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury Tekijä Sunfa Cheng, Allan S. Pollock, Rajeev Mahimkar, Jean L. Olson, David H. Lovett, Sunfa Cheng, Allan S. Pollock, Rajeev Mahimkar, Jean L. Olson, David H. Lovert

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers

    A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodi... Tekijä Marina Bergman, Sunfa Cheng, Norman Honbo, Lucia Piacentini, Joel S. Karliner, David H. Lovett

    Julkaistu 2003
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity

    Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity Tekijä Munro Peacock, John P. Bilezikian, Michael A. Bolognese, Michael Borofsky, Simona Scumpia, Lulu Ren Sterling, Sunfa Cheng, Dolores Shoback

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults

    A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults Tekijä Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, Koichi Hirata, Robert Lenz, Yi Wang, Sunfa Cheng, Toshiyasu Hirama, Daniel D. Mikol

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study

    Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study Tekijä Takao Takeshima, Fumihiko Sakai, Koichi Hirata, Noboru Imai, Yasuhiko Matsumori, Ryuji Yoshida, Cheng Peng, Sunfa Cheng, Daniel D. Mikol

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism

    Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism Tekijä Claudio Marcocci, Philippe Chanson, Dolores Shoback, John P. Bilezikian, Laureano Fernández‐Cruz, Jacques Orgiazzi, Christoph Henzen, Sunfa Cheng, Lulu Ren Sterling, John Lu, Munro Peacock

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Erenumab in chronic migraine with medication overuse

    Erenumab in chronic migraine with medication overuse Tekijä Stewart J. Tepper, Hans‐Christoph Diener, Messoud Ashina, Jan Lewis Brandes, Deborah I. Friedman, Uwe Reuter, Sunfa Cheng, Jon Nilsen, Dean Leonardi, Robert Lenz, Daniel D. Mikol

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Erenumab in chronic migraine

    Erenumab in chronic migraine Tekijä Richard B. Lipton, Stewart J. Tepper, Uwe Reuter, Stephen D. Silberstein, Walter F. Stewart, Jon Nilsen, Dean Leonardi, Pooja Desai, Sunfa Cheng, Daniel D. Mikol, Robert Lenz

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

    Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial Tekijä Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Fei Xue, Feng Zhang, Gabriel Paiva da Silva Lima, Sunfa Cheng, Daniel D. Mikol

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine

    Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine Tekijä Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Gregory A. Rippon, Jan Klatt, Fei Xue, Victoria Chia, Feng Zhang, Sunfa Cheng, Daniel D. Mikol

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Vascular safety of erenumab for migraine prevention

    Vascular safety of erenumab for migraine prevention Tekijä David Kudrow, Julio Pascual, Paul Winner, David W. Dodick, Stewart J. Tepper, Uwe Reuter, Frank Hong, Jan Klatt, Feng Zhang, Sunfa Cheng, Hernàn Picard, Osa Eisele, Julie Wang, Jonathan N. Latham, Daniel D. Mikol

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

    Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism Tekijä Geoffrey A. Block, David A. Bushinsky, Sunfa Cheng, John Cunningham, Bastian Dehmel, Tilman B. Drüeke, Markus Ketteler, Reshma Kewalramani, Kévin Martin, Sharon M. Moe, Uptal D. Patel, Justin Silver, Yan Sun, Hao Wang, Glenn M. Chertow

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel

    Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel Tekijä David Henner, Beatrice Drambarean, Teresa Gerbeling, Jessica Kendrick, William T. Kendrick, Lisa Koester-Wiedemann, Thomas L. Nickolas, Anjay Rastogi, Anis Abdul Rauf, Brenda Dyson, Michael C. Singer, Pooja Desai, Kathleen M. Fox, Sunfa Cheng, William G. Goodman

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Early onset of efficacy with erenumab in patients with episodic and chronic migraine

    Early onset of efficacy with erenumab in patients with episodic and chronic migraine Tekijä Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper, Messoud Ashina, David Kudrow, Gregor Broessner, Guy Boudreau, Peter McAllister, Thuy Vu, Feng Zhang, Sunfa Cheng, Hernàn Picard, Shihua Wen, Joseph M. Kahn, Jan Klatt, Daniel D. Mikol

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure Tekijä Karl Swedberg, James B. Young, Inder S. Anand, Sunfa Cheng, Akshay S. Desai, Rafael Díaz, Aldo P. Maggioni, John J.V. McMurray, Christopher O’Connor, Marc A. Pfeffer, Scott D. Solomon, Yan Sun, Michał Tendera, Dirk J. van Veldhuisen

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study

    Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study Tekijä Paul Welsh, Lei Kou, Changhong Yu, Inder S. Anand, Dirk J. van Veldhuisen, Aldo P. Maggioni, Akshay S. Desai, Scott D. Solomon, Marc A. Pfeffer, Sunfa Cheng, Lars Gullestad, Pål Aukrust, Thor Ueland, Karl Swedberg, James B. Young, Michael W. Kattan, Naveed Sattar, John J.V. McMurray

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: